Quick search
Go!

THE USE OF TUMOR MARKERS IN PREVENTING AND DIAGNOSING CANCER


MARIA PRISECARU 1, IONUţ STOICA 2, NICOLETA BăDăLUţă 3
University „Vasile Alecsandri” of Bacau, Faculty of Science, Department of Biology, Ecology and Environment Protection, Marasesti Street, no. 157, Romania e-mail: 1. prisecaru_maria@yahoo.com;
2. ionut_stoica23@yahoo.com;
3. nicoletadogaru@yahoo.com

Issue:

SCSB, Number 2, Volume XXI

Section:

Volume 21, No.2 - Animal Biology

Abstract:

In using tumor markers for early

diagnosis and at early stages of neoplasm cases

in the period March 2004 - September 2010,

18,830 samples were processed, of which 10

574 samples were confirmed with a diagnosis of

cancer of various types, primary and metastatic

forms. The markers used were: hepatic (AFP,

CEA, CA 19-9), pancreatic (CEA, CA19-9), of

prostatic (CEA, PSA, acid and alkaline

phosphatase), breast (CEA, AC15-3, CA27, 29),

genital (CEA, CA125), lung (CEA),

gastrointestinal (CEA). The investigations were

conducted using the apparata LISA 200, Miura

9.2 and ELISA on peripheral blood.

The high frequency of this serious

disease in the study group (40.5% subjects with

confirmed cancer) should be a warning to

reconsider our lifestyle, habits and nutrition.

Keywords:

tumour markers, rapid and early diagnosis, screening tests.

Code [ID]:

SCSB20122102V21S01A0006 [0003763]


Copyright (c) 1995-2007 University of Bacu